FDA approves Tukysa for advanced, unresectable or metastatic HER2-positive breast cancer April 20, 2020
Pemazyre approved in U.S. for advanced cholangiocarcinoma with FGFR2 fusions or rearrangements April 20, 2020
Koselugo receives FDA approval for pediatric patients with NF1-related plexiform neurofibromas April 14, 2020
RSS